UnitedHealth Group Incorporated (NYSE:UNH) Stake Boosted by Fulcrum Capital LLC

Fulcrum Capital LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.4% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 24,013 shares of the healthcare conglomerate's stock after purchasing an additional 1,452 shares during the period. UnitedHealth Group comprises about 2.8% of Fulcrum Capital LLC's investment portfolio, making the stock its 9th biggest position. Fulcrum Capital LLC's holdings in UnitedHealth Group were worth $12,577,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Capital & Planning LLC boosted its position in UnitedHealth Group by 19.2% during the 4th quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock valued at $248,000 after buying an additional 79 shares during the period. Brighton Jones LLC lifted its position in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Union Bancaire Privee UBP SA purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $27,233,000. Revolve Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. Finally, Cyr Financial Inc. lifted its position in shares of UnitedHealth Group by 11.1% in the 4th quarter. Cyr Financial Inc. now owns 1,515 shares of the healthcare conglomerate's stock worth $766,000 after purchasing an additional 151 shares during the period. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $2.91 during trading hours on Friday, reaching $301.08. The company had a trading volume of 16,265,624 shares, compared to its average volume of 6,788,348. The business has a fifty day moving average price of $430.87 and a 200-day moving average price of $493.45. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The firm has a market cap of $273.12 billion, a PE ratio of 19.42, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kristen Gil purchased 3,700 shares of the stock in a transaction on Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director now directly owns 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. TD Securities reaffirmed a "hold" rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. JPMorgan Chase & Co. lowered their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research report on Thursday, May 15th. Finally, Wolfe Research lowered their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $441.87.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.